Clinical Trials Directory

Trials / Completed

CompletedNCT02905851

Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris

Detailed description

The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use. There are two arms of the study: 1. Feedback group 2. Non feedback group All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months). The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.

Conditions

Interventions

TypeNameDescription
OTHERFeedback groupMonitoring ability to use teledermatology to modify antibiotic burden
OTHERNon Feedback groupTo use as control to see if antibiotic burden has been reduced in the active feedback group

Timeline

Start date
2016-05-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2016-09-19
Last updated
2018-07-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02905851. Inclusion in this directory is not an endorsement.